Voyager Therapeutics is trading 5.4% down at $3.48 amid light company news flow and a generally mixed broader market backdrop.
- The stock's move appears tied to recent technical weakness and low-conviction trading rather than a specific new development.
- There have been no fresh earnings, FDA updates, partnership announcements, or analyst-rating headlines reported this morning.